Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
Details for Australian Patent Application No. 2003240984 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 02/04220 04.04.02 FR
27 November 2003 Application Open to Public Inspection
Published as AU-B-2003240984
17 February 2005 Change of Name(s) of Applicant(s), Section 104
Sanofi-Synthelabo The name of the applicant has been changed to Sanofi-Aventis
31 July 2008 Application Accepted
Published as AU-B-2003240984
27 November 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser